PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 46.00 thousand shares for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 7.50K shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 2.20K shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 31.20K shares, a 447.37% increase year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 5.10K shares, a 48.48% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2026 was 46.00K shares, a 194.87% increase from fiscal 2025.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 15.60K shares, a 61.95% decline from fiscal 2024.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 41.00K shares, a 298.06% increase from fiscal 2023.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 10.30K shares, a 24.82% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 7.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 9.70K shares derived: sum of 2 quarters · filed 2026-05-14 | 40.90K shares derived: sum of 3 quarters · filed 2026-05-14 | 46.00K shares 10-K · filed 2026-05-14 |
| 2025-12-31 | 2.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | 33.40K shares derived: sum of 2 quarters · filed 2026-02-05 | 38.50K shares 10-Q · filed 2026-02-05 | 38.50K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | 31.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 36.30K shares 10-Q · filed 2025-11-06 | 36.30K shares derived: sum of 3 quarters · filed 2026-08-06 | 36.30K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 5.10K shares 10-Q · filed 2026-08-06 | 5.10K shares derived: sum of 2 quarters · filed 2026-08-06 | 5.10K shares derived: sum of 3 quarters · filed 2026-08-06 | 10.80K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 5.70K shares derived: sum of 3 quarters · filed 2026-05-14 | 15.60K shares 10-K · filed 2026-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | 5.70K shares derived: sum of 2 quarters · filed 2026-02-05 | 15.60K shares 10-Q · filed 2026-02-05 | 15.60K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-09-30 | 5.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 15.60K shares 10-Q · filed 2025-11-06 | 15.60K shares derived: sum of 3 quarters · filed 2026-05-14 | 20.80K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-06-30 | 9.90K shares 10-Q · filed 2025-08-07 | 9.90K shares derived: sum of 2 quarters · filed 2026-05-14 | 15.10K shares derived: sum of 3 quarters · filed 2026-05-14 | 31.60K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 5.20K shares derived: sum of 2 quarters · filed 2026-05-14 | 21.70K shares derived: sum of 3 quarters · filed 2026-05-14 | 41.00K shares 10-K · filed 2026-05-14 |
| 2023-12-31 | 5.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | 21.70K shares derived: sum of 2 quarters · filed 2025-02-06 | 41.00K shares 10-Q · filed 2025-02-06 | 41.00K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-09-30 | 16.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | 35.80K shares 10-Q · filed 2024-11-07 | 35.80K shares derived: sum of 3 quarters · filed 2025-05-09 | |
| 2023-06-30 | 19.30K shares 10-Q · filed 2024-08-08 | 19.30K shares derived: sum of 2 quarters · filed 2025-05-09 | ||
| 2023-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09 | 10.30K shares 10-K · filed 2025-05-09 | ||
| 2022-12-31 | 10.30K shares 10-Q · filed 2024-02-08 | |||
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-15 | 4.50K shares derived: sum of 3 quarters · filed 2024-05-15 | 13.70K shares 10-K · filed 2024-05-15 |
| 2021-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-02 | 4.50K shares derived: sum of 2 quarters · filed 2023-02-02 | 13.70K shares 10-Q · filed 2023-02-02 | 35.40K shares derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-09-30 | 4.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | 13.70K shares 10-Q · filed 2022-11-03 | 35.40K shares derived: sum of 3 quarters · filed 2023-05-05 | 35.40K shares derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-06-30 | 9.20K shares 10-Q · filed 2022-08-04 | 30.90K shares derived: sum of 2 quarters · filed 2023-05-05 | 30.90K shares derived: sum of 3 quarters · filed 2023-05-05 | |
| 2021-03-31 | 21.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05 | 21.70K shares derived: sum of 2 quarters · filed 2023-05-05 | 21.70K shares 10-K · filed 2023-05-05 | |
| 2020-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | 0.00 shares 10-Q · filed 2022-02-03 | ||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-04 | |||
| 2020-03-31 | 79.20K shares 10-K · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |